GEODE CAPITAL MANAGEMENT, LLC
Position in ATNM — Actinium Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ATNM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$334,392
-$113,039 QoQ
Shares Held
336,073
+2.2% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. ATNM ranks #384 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ATNM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $334,392 | 336,073 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $447,431 | 328,994 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $525,470 | 328,419 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $461,564 | 329,689 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,145,998 | 711,801 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $866,694 | 687,853 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,289,967 | 686,153 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,930,693 | 666,310 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $4,664,487 | 595,720 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,893,308 | 569,549 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,211,238 | 542,439 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,868,647 | 521,381 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,196,482 | 232,432 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,467,455 | 231,686 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,580,545 | 214,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $828,363 | 172,217 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $854,248 | 167,172 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,004,703 | 167,172 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,481,143 | 167,172 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,207,682 | 152,678 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $760,521 | 99,806 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $778,486 | 99,806 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $967,120 | 99,806 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||